GlassScriptPhysician profile
Chadd Scott Murray
NPI 1134203920
$2,924.15
in general payments reported to CMS, 2019-2025
20 companies · $643 in 2025
The $643 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $54.18 · 2021: $209 · 2022: $447 · 2023: $768 · 2024: $669 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,819.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $210.59 | 2020-2025 | Breztri, Farxiga, Fasenra |
| Novartis Pharmaceuticals Corporation | $134.55 | 2023-2025 | |
| Lilly USA, LLC | $113.39 | 2022-2025 | Mounjaro, Jardiance |
| Novo Nordisk INC | $109.71 | 2020-2025 | Ozempic, Rybelsus |
| Kerecis Limited | $73.91 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Pfizer INC. | $69.25 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $67.39 | 2019-2022 | |
| Amgen INC. | $58.29 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.62 | 2019 | |
| Allergan, INC. | $39.76 | 2019 | |
| Sanofi Pasteur INC. | $29.96 | 2020-2024 | |
| Astellas Pharma US INC | $27.35 | 2025 | Veozah |
| Actelion Pharmaceuticals US, INC. | $26.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.15 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $16.89 | 2019 | |
| Abbott Laboratories | $15.49 | 2024 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $14.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.81 | 2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadd Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.